NLRP3 and hepatocellular carcinoma: Therefore, we hypothesized that the AL365361.1/hsa-miR-17-5p/NLRP3 axis may be related to the ICIs sensitivity of HCC patients, which is the main reason for the difference in immune response and OS between the two risk groups.